228 related articles for article (PubMed ID: 31347149)
1. Pharmacology of bisphosphonates in pain.
Tzschentke TM
Br J Pharmacol; 2021 May; 178(9):1973-1994. PubMed ID: 31347149
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates for delivering drugs to bone.
Sun S; Tao J; Sedghizadeh PP; Cherian P; Junka AF; Sodagar E; Xing L; Boeckman RK; Srinivasan V; Yao Z; Boyce BF; Lipe B; Neighbors JD; Russell RGG; McKenna CE; Ebetino FH
Br J Pharmacol; 2021 May; 178(9):2008-2025. PubMed ID: 32876338
[TBL] [Abstract][Full Text] [Related]
3. Overview of treatment approaches to osteoporosis.
Langdahl BL
Br J Pharmacol; 2021 May; 178(9):1891-1906. PubMed ID: 32060897
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in targeting ion channels to treat chronic pain.
Stevens EB; Stephens GJ
Br J Pharmacol; 2018 Jun; 175(12):2133-2137. PubMed ID: 29878335
[TBL] [Abstract][Full Text] [Related]
5. PPARs and pain.
Okine BN; Gaspar JC; Finn DP
Br J Pharmacol; 2019 May; 176(10):1421-1442. PubMed ID: 29679493
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targets in myeloma bone disease.
Marino S; Petrusca DN; Roodman GD
Br J Pharmacol; 2021 May; 178(9):1907-1922. PubMed ID: 31647573
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel modulation as a target in chronic pain control.
Patel R; Montagut-Bordas C; Dickenson AH
Br J Pharmacol; 2018 Jun; 175(12):2173-2184. PubMed ID: 28320042
[TBL] [Abstract][Full Text] [Related]
8. How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders.
Kimura LF; Novaes LS; Picolo G; Munhoz CD; Cheung CW; Camarini R
Br J Pharmacol; 2022 Apr; 179(8):1640-1660. PubMed ID: 34076891
[TBL] [Abstract][Full Text] [Related]
9. Cellular metabolism and diseases.
Maiuri MC; Maffia P
Br J Pharmacol; 2021 May; 178(10):2031-2033. PubMed ID: 33932230
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
Gaborit M; Massotte D
Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
[TBL] [Abstract][Full Text] [Related]
11. Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field.
Moran MM; Szallasi A
Br J Pharmacol; 2018 Jun; 175(12):2185-2203. PubMed ID: 28924972
[TBL] [Abstract][Full Text] [Related]
12. Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics.
Yanow J; Pappagallo M; Pillai L
ScientificWorldJournal; 2008 Feb; 8():229-36. PubMed ID: 18661047
[TBL] [Abstract][Full Text] [Related]
13. Fifteen years of Na
Eagles DA; Chow CY; King GF
Br J Pharmacol; 2022 Jul; 179(14):3592-3611. PubMed ID: 33206998
[TBL] [Abstract][Full Text] [Related]
14. P2X receptor channels in chronic pain pathways.
Bernier LP; Ase AR; Séguéla P
Br J Pharmacol; 2018 Jun; 175(12):2219-2230. PubMed ID: 28728214
[TBL] [Abstract][Full Text] [Related]
15. Histamine, histamine receptors, and neuropathic pain relief.
Obara I; Telezhkin V; Alrashdi I; Chazot PL
Br J Pharmacol; 2020 Feb; 177(3):580-599. PubMed ID: 31046146
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain.
Lee JYP; Saez NJ; Cristofori-Armstrong B; Anangi R; King GF; Smith MT; Rash LD
Br J Pharmacol; 2018 Jun; 175(12):2204-2218. PubMed ID: 29134638
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance.
Puppo M; Taipaleenmäki H; Hesse E; Clézardin P
Br J Pharmacol; 2021 May; 178(9):1936-1954. PubMed ID: 31423566
[TBL] [Abstract][Full Text] [Related]
18. Possible mechanisms of cancer prevention by nicotinamide.
Buqué A; Bloy N; Kroemer G; Galluzzi L
Br J Pharmacol; 2021 May; 178(10):2034-2040. PubMed ID: 32383227
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in chronic obstructive pulmonary disease.
Gredic M; Blanco I; Kovacs G; Helyes Z; Ferdinandy P; Olschewski H; Barberà JA; Weissmann N
Br J Pharmacol; 2021 Jan; 178(1):132-151. PubMed ID: 31976545
[TBL] [Abstract][Full Text] [Related]
20. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
